What You Should Know:
- Goldman Sachs Asset Management has announced the closing of its first-ever life sciences fund, West Street Life Sciences I, surpassing its target with $650 million in commitments.
- This marks a significant investment in the burgeoning life sciences sector, showcasing Goldman Sachs' confidence in the field's potential to revolutionize healthcare.
West Street Life Sciences Investment Thesis
The fund will focus on growth-oriented private equity investments in
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Lilly Simplifies Chronic Disease Management with New Digital Platform: LillyDirect
What You Should Know:
- Eli Lilly and Company (NYSE: LLY) announced today the launch of LillyDirect™, a comprehensive digital healthcare platform designed to empower patients living with obesity, migraine, and diabetes in the U.S. This innovative initiative aims to simplify chronic disease management by offering convenient resources, personalized support, and direct home delivery of select Lilly medications.
Key Features of LillyDirect
LillyDirect Pharmacy Solutions: This digital
Read More
Mission Bio Appoints Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions
What You Should Know:
- Mission Bio, a pioneer in single-cell multiomic solutions for precision medicine, announced today the appointment of Brian Kim as its new Chief Executive Officer.
- Kim brings over two decades of life sciences expertise and a proven track record of driving growth and innovation to the company, poised to propel Mission Bio's technology into clinical applications.
Brian Kim Bio/Background
Kim's career boasts a series of successes in the life sciences sphere,
Read More
knownwell Launches Pediatric Metabolic Health Offering as Childhood Obesity Rates Continue to Rise
What You Should Know:
knownwell, a fully integrated virtual and in-person weight-inclusive healthcare company, today announced the launch of knownwell teens, an early intervention clinical offering designed to support the 14 million children and teens living with obesity in the United States.Created by knownwell’s renowned metabolic health experts, this new model aims to empower patients on their wellness journey through the company's clinically-rigorous care model.
Redoubling the
Read More
Absci, PrecisionLife Partner to Develop AI-Enabled Drug Pipeline
What You Should Know:
- Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced a powerful partnership to develop a joint portfolio of potential therapeutics.
- This collaboration aims to leverage the strengths of both companies to address unmet medical needs and accelerate drug development.
Combining Expertise for Faster, Precision-Driven Drug Discovery
Key aspects of the partnership
Read More
How Intelligent Document Processing (IDP) Revolutionizes Clinical Trials
In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.
The clinical trial space is one area where pharmaceutical companies are leveraging these technologies to improve operations, in particular, data processing. A typical clinical trial generates over 13,000 documents in various formats, including text, audio, video and images, making it
Read More
UNP Scores $32M for AI-Powered Macrocycle Therapeutics
What You Should Know:
- Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding.
- Led by Merck Global Health Innovation Fund (MGHIF) and TechBio-focused ARTIS Ventures, the funding will help propel UNP's innovative platform and expand its reach beyond oncology, tackling a wider range of medical challenges.
Macrocycles: Nature's Key to Untapped Drug
Read More
ARTIS Ventures Closes $200M TechBio Fund to Support Next Era of Health & Medicine Innovation
What You Should Know:
- ARTIS Ventures, a pioneer in this "TechBio" revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation.
- The fund aims to support early-stage companies to transform human health and well-being by leveraging growing data sets, advanced analytics, and insights.
TechBio II Investment Thesis
Diseases once deemed incurable now have hope, personalized therapies are becoming a reality, and the human body
Read More
AstraZeneca Acquires Icosavax for $1.1B to Advance RSV and hMPV Vaccine Development
What You Should Know:
- AstraZeneca has announced the acquisition of Icosavax, a biopharmaceutical company developing a promising vaccine targeting both RSV and hMPV, for a total of up to $1.1 billion.
- This acquisition strengthens AstraZeneca's respiratory pipeline and aligns with their strategy of addressing high unmet needs in infectious diseases.
Building on Expertise in RSV Prevention
Icosavax's lead program, IVX-A12, is a Phase III-ready vaccine candidate targeting both
Read More
Medtronic Expands AI-Driven Partnership with Cosmo Pharmaceuticals to Transform Endoscopy
What You Should Know:
- Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV, a pharmaceutical company, to further advance AI-powered solutions in the medical field.
- This strategic alliance builds upon the success of the GI Genius™ intelligent endoscopy module, aiming to revolutionize endoscopy through AI and improve patient outcomes globally.
Partnership Benefits
Building upon the success of the GI Genius™ intelligent endoscopy module, the partnership will
Read More
